Perimyocarditis Following COVID-19 Vaccination

5Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A 39-year-old male was admitted in the emergency room with chest pain. He had been given the second dose of Pfizer–BioNTech COVID-19 vaccine 3 days before. The patient denied taking any other medication beyond the usual. He didn’t feel sick in the previous days/weeks. Laboratory studies revealed elevated serum levels of troponin and C-reactive protein. An autoantibody screen and a serologic panel to detect common viruses were negative. A cardiac MRI showed myocardial edema/inflammation and confirmed the diagnosis of perimyocarditis which was considered to be a consequence of COVID-19 vaccination. Physicians should be aware of the possibility of cardiovascular complications after COVID-19 vaccination.

Cite

CITATION STYLE

APA

Tinoco, M., Leite, S., Faria, B., Cardoso, S., Von Hafe, P., Dias, G., … Lourenço, A. (2021). Perimyocarditis Following COVID-19 Vaccination. Clinical Medicine Insights: Cardiology, 15. https://doi.org/10.1177/11795468211056634

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free